Sirtuins Suggest an improvement to this article

Contents

  1. Sirtuin regulation as a cellular sensor
  2. Sirtuin-activating compounds (SACs)
  3. Physiological roles of sirtuins
    1. Sirtuins as an enhancer of fuel utilization
      1. Fatty acid oxidation
      2. Glucose metabolism
    2. Sirtuins as modulators of inflammation
    3. Sirtuins as mediators of autophagy
    4. Circadian regulation
    5. Neuroprotection and slowed cognitive aging
    6. Cancer
  4. Conclusion
Sirtuins episodes Sirtuins news

Sirtuins are highly conserved enzymes that play key roles in healthspan and longevity in multiple organisms. They are linked to the regulation of a variety of metabolic processes, including the release of insulin, mobilization of lipids, response to stress, and modulation of lifespan.[1] [2] Sirtuins have been implicated in the pathophysiology of metabolic disorders such as type 2 diabetes; neurological disorders such as Parkinson’s disease; and many other conditions related to aging.[3] [4] [5]

Sirtuins respond to physiological changes in energy levels, thereby regulating energy homeostasis and health. There are seven known sirtuins in mammals (SIRT1 to SIRT7) with varied functions and cellular localizations. The most extensively studied sirtuin, SIRT1, has been shown to modulate histones, transcription factors, and DNA repair proteins – all genome level processes thought to play important roles in aging. Broad loss of sirtuin activity is typically observed with aging, and many animal models demonstrate that decreased SIRT1 activity may promote the pathogenesis of both cardiovascular and neurological diseases.[6] [7] Conversely, increased sirtuin activity delays the processes of aging and mediates many of the beneficial effects seen with caloric restriction, one of the few successful aging interventions that demonstrates lifespan extension across virtually all major scientific models of aging, ranging from single celled organisms to primates.[8]

Sirtuin regulation as a cellular sensor

Fasting, caloric restriction, exercise, and NAD+ boosters nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) all increase NAD+, leading to activation of SIRT1 and SIRT3 and resulting in a myriad of tissue-specific effects that improve healthspan. Sirtuin-activating compounds such as resveratrol and pterostilbene directly activate SIRT1.

Sirtuin activity is regulated by dynamic changes in cellular levels of nicotinamide adenine dinucleotide, or NAD+, a coenzyme that is required for the production of energy in cells. Manipulation of cellular levels of NAD+ offers a promising strategy for aging interventions. For example, supplementation with nicotinamide riboside, a form of vitamin B3 (also known as niacin) may increase NAD+ levels within the cells of some tissues, stimulating some of the cellular changes associated with the benefits of caloric restriction.

Sirtuins utilize NAD+ to remove specific chemical structures called acetyl groups – a process called deacetylation – from cellular proteins to control transcriptional regulation, energy metabolism, circadian rhythms, DNA repair, and cell survival. When cellular energy levels are low, such as during exercising, fasting, or caloric restriction, the ratio of NAD+ to its reduced form, NADH, increases, thereby serving as a "sensor" to switch on sirtuin expression and subsequent activity.

Caloric restriction, in particular, has been shown to increase lifespan in mice and decrease age-related disease in humans, mediated through the increased expression of Sirt1, Sirt3, and Sirt5 (in mice) and SIRT1 (in humans). [9] [10] [11] Transgenic mice that overexpress Sirt1 display phenotypes that are similar to mice fed a calorie-restricted diet, including reduced blood cholesterol and insulin levels, improved glucose tolerance, and decreased body weights, compared to wild-type mice.[12] Conversely, mice that lack the Sirt1 gene have a shorter lifespan than wild-type animals, and the lifespan-enhancing benefits of a calorie-restricted diet are negated.[13] [14] [15] Aging and states of excess cellular energy, however, such as obesity or eating a high-fat diet, result in a loss of sirtuin activity in both mice and humans, possibly providing a mechanism for the links between excess energy intake and metabolic dysregulation.[16] [17] [18]

Learn more about the role of NAD+ in aging in this episode featuring Dr. Eric Verdin.

Sirtuin-activating compounds (SACs)

Some naturally occurring and synthetic compounds, called sirtuin-activating compounds, mimic conditions of low cellular energy. Sirtuin activating compounds bind to sirtuins, altering their affinity for NAD+ and their protein substrates, thereby increasing sirtuins' activity. A growing body of evidence suggests that sirtuin-activating compounds show promise as therapeutic approaches for treating metabolic dysfunction and age-related diseases.[6]

For example, resveratrol, a polyphenolic dietary compound found in red grapes, is a potent sirtuin activating compound that demonstrates protective effects against type 2 diabetes, cardiomyopathy, and cancer.[19] [20] [21]

"Resveratrol, a polyphenolic dietary compound found in red grapes, is a potent sirtuin activating compound that demonstrates protective effects against type 2 diabetes, cardiomyopathy, and cancer." Click To Tweet

Learn more about depression in this overview article.

Pterostilbene, a polyphenolic compound that is related to resveratrol, is found in blueberries, cranberries, and almonds. Like resveratrol, pterostilbene is a sirtuin activating compound. However, pterostilbene's molecular structure makes it more bioavailable – as much four times more pterostilbene is taken up into the bloodstream as resveratrol upon ingestion.[22] Some studies suggest that pterostilbene is more potent than resveratrol when it comes to improving brain function, averting some types of cancer, and preventing heart disease.[23] It also demonstrates greater potency than resveratrol in improving cognitive function in progeria aged mice.[24] However, in a randomized, double-blind, and placebo-controlled study involving 80 people who had high cholesterol, participants who took a pterostilbene supplement twice daily for six to eight weeks exhibited increased LDL levels.[25]

Finally, metformin, a drug commonly used to treat diabetes, demonstrates potent sirtuin activating capacity. Like resveratrol and pterostilbene, metformin binds to specific sites on SIRT1. In turn, it improves the enzymatic efficiency of SIRT1 when cellular levels of NAD+ are low.[26] Learn more about metformin in this overview article.

Physiological roles of sirtuins

Sirtuins play many roles across a broad spectrum of disease states and biological processes, including those that have the capacity to modulate the onset of age-related diseases such as neurodegenerative disorders and metabolic dysfunction.

Sirtuins as an enhancer of fuel utilization

Under conditions of energy excess, fats are stored as fatty acids within specialized cells called white adipocytes, and glucose is stored as glycogen in the liver and muscles. When the body is stressed due to low energy levels, it undergoes a metabolic shift that facilitates the use of stored nutrients via the processes of fatty acid oxidation and glucose metabolism.

Fatty acid oxidation

SIRT1 activity promotes fat mobilization from white adipocytes and inhibits adipogenesis (the process by which adipocytes mature) by suppressing activity of the transcription factor PPAR-gamma.[27] It also promotes fatty acid oxidation in skeletal muscle while suppressing its synthesis in the liver.[28] Overexpression of SIRT1 protects mice from hepatic steatosis, a condition characterized by fat accumulation in the liver. Conversely, deletion of the SIRT1 gene promotes hepatic steatosis via increased fatty acid synthesis.[29] [30] [31]

Mitochondria are critical to the utilization of fatty acids. Mitochondrial biogenesis, the process by which new mitochondria are produced in cells, is regulated by the transcription factor PGC-1α. SIRT1 promotes the synthesis of PGC1-α to induce mitochondrial biogenesis in several cell types.[32] [33]

Glucose metabolism

SIRT1 activity also stimulates the transcription of proteins involved in gluconeogenesis – the production of glucose from non-carbohydrate precursors – by activating FOXO1.[34] [35] However, when energy levels are high, SIRT1 activity inhibits glucose metabolism (glycolysis) by suppressing the transcription of proteins involved in the glycolytic process.[32] SIRT1 also regulates insulin secretion from the pancreas, a process tightly coupled to blood glucose levels, by suppressing the activity of uncoupling protein 2, a protein that participates in energy production in the cell, leading to an increase of pancreatic ATP and, subsequently, insulin release.[36]

Sirtuins as modulators of inflammation

Chronic local inflammation in tissues such as the liver and adipose tissue is a hallmark of metabolic syndrome, a collection of disorders that increases a person's risk of developing cardiovascular disease, diabetes, fatty liver, and several types of cancer.[37] [38] SIRT1 has been shown to modulate inflammation by suppressing the activity of NF-κB, a family of inducible transcription factors that regulates genes involved in various immune and inflammatory responses.[39] However, deleting the SIRT1 gene in mouse macrophages (a type of white blood cell of the immune system) leads to increased inflammatory gene expression within the cells.[40]

Sirtuins as mediators of autophagy

Autophagy is a critical cellular defense mechanism that facilitates the removal of damaged or dysfunctional cellular components. It is a key player in the regulation of the aging process. Multiple studies demonstrate that SIRT1 mediates autophagy induction by interacting with components of the autophagy machinery such as FOXO1 and FOXO3a.[41] [42]

Learn more about autophagy in this overview article.

Circadian regulation

The circadian system is highly intertwined with an organism's metabolism to optimize performance over a 24-hour cycle. Sirtuins have been shown to regulate the circadian clocks in both brain and peripheral tissues.

In the suprachiasmatic nucleus of the brain, SIRT1 is expressed in a circadian manner and can regulate the expression of core clock genes CLOCK and BMAL1. SIRT1 has been shown to directly bind to CLOCK/BMAL1 to promote the deacetylation of BMAL1, thereby influencing its activity.[43] Furthermore, SIRT1 can also promote the degradation of PER2, a protein that regulates circadian rhythms of metabolism, locomotor activity, and behavior.[44]

In the liver, SIRT1 modulates the circadian expression of acetyl-CoA synthetase 1, an enzyme that controls fatty acid elongation by producing acetyl-CoA.[45] SIRT6 has also been shown to interact with CLOCK/BMAL and can control the cyclic expression of the transcription factor SREBP-1, which is important for regulating aspects of lipid metabolism such as fatty acid synthesis and storage.[46]

Some evidence suggests that sirtuin activating compounds can restore the circadian rhythmic dysregulation of lipid metabolism induced by high-fat diet feeding in mice by acting as a zeitgeber signal – an external cue that has the capacity to influence the body's internal clocks.[47] Preliminary data in liver cells have shown that insulin resistance due to circadian dysregulation can be recovered through the activation of SIRT1 by resveratrol. [48]

To learn more about the importance of maintaining circadian rhythmicity for health, see this episode with Dr. Satchin Panda

Neuroprotection and slowed cognitive aging

SIRT1 is ubiquitous in the mammalian brain; however, levels decrease with aging, high-fat diet eating, and neuropathological conditions.[49] [50] In animal models, deletion of the SIRT1 gene impairs cognitive functions such as short and long-term associative memory, as well as spatial learning.[51] [52] Furthermore, in rodent models of Alzheimer's disease, SIRT1 activation with resveratrol or via genetic overexpression reduces amyloid plaque formation and consequently delays neurodegeneration and cognitive decline. [53] [54] [55] [56]

In humans, two separate studies demonstrated that SIRT1 activity is reduced in post-mortem brain tissue obtained from people who had Alzheimer's disease and Parkinson's disease.[57] [58] In addition, a randomized, placebo-controlled, double-blind trial involving people diagnosed with mild-to-moderate dementia due to Alzheimer's disease found that participants who took a resveratrol supplement twice a day (up to 1 gram) for one year exhibited reduced levels of MMP9, a neurological inflammatory marker associated with increased neurodegeneration and inflammation. The participants also showed improvements in mental status and their ability to carry out activities of daily living.[59] While these studies support the idea of SIRT1 influencing the pathophysiology of Alzheimer's disease, more clinical studies are necessary to investigate whether targeting SIRT1 will display positive outcomes in patients with neurological diseases.

Resveratrol is a component of the Bredesen Protocol to slow cognitive decline. Click here to learn more about Dr. Dale Bredesen's take on Alzheimer's disease.

Cancer

An abundance of data indicates that sirtuins act as both tumor-suppressors and tumor-promoters in various types of cancer. For example, whereas overexpression of SIRT1 suppresses tumor growth in colon cancer, its upregulation promotes tumor growth in gastric cancer.[60] [61] One or both copies of the SIRT3 gene is absent in 20 percent of all cancers, a figure that is doubled in breast and ovarian cancers.[62] Genetic observations like these don't necessarily act as a signpost for expected whole-organism effects of sirtuin activating compounds, for example. However, they do provide a more complete picture of the way in which cancer can often hijack otherwise beneficial and life-sustaining mechanisms toward its own selfish objectives. Future animal trials and studies of human tissue will likely elucidate the roles that sirtuins play in various types of cancer.

Conclusion

Sirtuins are crucial cellular proteins that hold sway over a broad range of physiological processes, including circadian regulation, anti-inflammatory activity, metabolic adaptations, and neurological protection. As such, they present a promising therapeutic strategy to ameliorate age-related diseases and extend healthspan. The focus of current sirtuin-related research is centered on the use of NAD+ supplementation or sirtuin-activating compounds such as resveratrol to boost sirtuin activity to revert the disease process and promote healthy aging.

  1. ^ Chang, Hung-Chun, and Leonard Guarente. SIRT1 and other sirtuins in metabolism Trends in Endocrinology & Metabolism 25, no. 3 (March 2014): 138–45. https://doi.org/10.1016/j.tem.2013.12.001.
  2. ^ Lomb, David J., Gaëlle Laurent, and Marcia C. Haigis. Sirtuins regulate key aspects of lipid metabolism Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics Biochimica Et Biophysica Acta (BBA) - Proteins and Proteomics 1804, no. 8 (August 2010): 1652–57. https://doi.org/10.1016/j.bbapap.2009.11.021.
  3. ^ Kitada, Munehiro, Yoshio Ogura, Itaru Monno, and Daisuke Koya. Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function Frontiers in Endocrinology 10 (March 2019). https://doi.org/10.3389/fendo.2019.00187.
  4. ^ Tang, Bor Luen. Sirtuins as modifiers of Parkinson s disease pathology Journal of Neuroscience Research 95, no. 4 (July 2016): 930–42. https://doi.org/10.1002/jnr.23806.
  5. ^ Sack, M. N., and T. Finkel. Mitochondrial Metabolism, Sirtuins, and Aging Cold Spring Harbor Perspectives in Biology 4, no. 12 (December 2012): a013102–a013102. https://doi.org/10.1101/cshperspect.a013102.
  6. ^ a   b Kane, Alice E., and David A. Sinclair. Sirtuins and NAD thplus in the Development and Treatment of Metabolic and Cardiovascular Diseases Circulation Research 123, no. 7 (September 2018): 868–85. https://doi.org/10.1161/circresaha.118.312498.
  7. ^ Xu, Jing, Charlie W. Jackson, Nathalie Khoury, Iris Escobar, and Miguel A. Perez-Pinzon. Brain SIRT1 Mediates Metabolic Homeostasis and Neuroprotection Frontiers in Endocrinology 9 (November 2018). https://doi.org/10.3389/fendo.2018.00702.
  8. ^ Mattison, Julie A., Ricki J. Colman, T. Mark Beasley, David B. Allison, Joseph W. Kemnitz, George S. Roth, Donald K. Ingram, Richard Weindruch, Rafael de Cabo, and Rozalyn M. Anderson. Caloric restriction improves health and survival of rhesus monkeys Nature Communications 8, no. 1 (January 2017). https://doi.org/10.1038/ncomms14063.
  9. ^ Cohen, H. Y. Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase Science 305, no. 5682 (July 2004): 390–92. https://doi.org/10.1126/science.1099196.
  10. ^ Lombard, D. B., F. W. Alt, H.-L. Cheng, J. Bunkenborg, R. S. Streeper, R. Mostoslavsky, J. Kim, et al. Mammalian Sir2 Homolog SIRT3 Regulates Global Mitochondrial Lysine Acetylation Molecular and Cellular Biology 27, no. 24 (October 2007): 8807–14. https://doi.org/10.1128/mcb.01636-07.
  11. ^ Nakagawa, Takashi, David J. Lomb, Marcia C. Haigis, and Leonard Guarente. SIRT5 Deacetylates Carbamoyl Phosphate Synthetase 1 and Regulates the Urea Cycle Cell 137, no. 3 (May 2009): 560–70. https://doi.org/10.1016/j.cell.2009.02.026.
  12. ^ Bordone, Laura, Dena Cohen, Ashley Robinson, Maria Carla Motta, Ed Van Veen, Agnieszka Czopik, Andrew D. Steele, et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction Aging Cell 6, no. 6 (August 2007): 759–67. https://doi.org/10.1111/j.1474-9726.2007.00335.x.
  13. ^ Li, Ying, Wei Xu, Michael W. McBurney, and Valter D. Longo. SirT1 Inhibition Reduces IGF-I/IRS-2/Ras/ERK1/2 Signaling and Protects Neurons Cell Metabolism 8, no. 1 (July 2008): 38–48. https://doi.org/10.1016/j.cmet.2008.05.004.
  14. ^ Boily, Gino, Erin L. Seifert, Lisa Bevilacqua, Xiao Hong He, Guillaume Sabourin, Carmen Estey, Cynthia Moffat, et al. SirT1 Regulates Energy Metabolism and Response to Caloric Restriction in Mice PLoS ONE Edited by Edathara Abraham. 3, no. 3 (March 2008): e1759. https://doi.org/10.1371/journal.pone.0001759.
  15. ^ Mercken, Evi M., Jia Hu, Susan Krzysik-Walker, Min Wei, Ying Li, Michael W. McBurney, Rafael de Cabo, and Valter D. Longo. SIRT1 but not its increased expression is essential for lifespan extension in caloric-restricted mice Aging Cell 13, no. 1 (November 2013): 193–96. https://doi.org/10.1111/acel.12151.
  16. ^ Chalkiadaki, Angeliki, and Leonard Guarente. High-Fat Diet Triggers Inflammation-Induced Cleavage of SIRT1 in Adipose Tissue To Promote Metabolic Dysfunction Cell Metabolism 16, no. 2 (August 2012): 180–88. https://doi.org/10.1016/j.cmet.2012.07.003.
  17. ^ Pedersen, S B, J Ølholm, S K Paulsen, M F Bennetzen, and B Richelsen. Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women International Journal of Obesity 32, no. 8 (June 2008): 1250–55. https://doi.org/10.1038/ijo.2008.78.
  18. ^ Santos Costa, Cíntia dos, Thais Ortiz Hammes, Francieli Rohden, Rogério Margis, Josiane Woutheres Bortolotto, Alexandre Vontobel Padoin, Cláudio Cora Mottin, and Regina Maria Guaragna. SIRT1 Transcription Is Decreased in Visceral Adipose Tissue of Morbidly Obese Patients with Severe Hepatic Steatosis Obesity Surgery 20, no. 5 (December 2009): 633–39. https://doi.org/10.1007/s11695-009-0052-z.
  19. ^ Cao, Ming‑Ming, Xi Lu, Guo‑Dong Liu, Ying Su, Yan‑Bo Li, and Jin Zhou. Resveratrol attenuates type 2 diabetes mellitus by mediating mitochondrial biogenesis and lipid metabolism via Sirtuin type 1 Experimental and Therapeutic Medicine , October 2017. https://doi.org/10.3892/etm.2017.5400.
  20. ^ DOI: 10.1155/2017/4602715>
  21. ^ Chao, Sung-Chuan, Ying-Ju Chen, Kuo-How Huang, Kuan-Lin Kuo, Ting-Hua Yang, Kuo-Yuan Huang, Ching-Chia Wang, Chih-Hsin Tang, Rong-Sen Yang, and Shing-Hwa Liu. Induction of sirtuin-1 signaling by resveratrol induces human chondrosarcoma cell apoptosis and exhibits antitumor activity Scientific Reports 7, no. 1 (June 2017). https://doi.org/10.1038/s41598-017-03635-7.
  22. ^ Kapetanovic, Izet M., Miguel Muzzio, Zhihua Huang, Thomas N. Thompson, and David L. McCormick. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats Cancer Chemotherapy and Pharmacology 68, no. 3 (November 2010): 593–601. https://doi.org/10.1007/s00280-010-1525-4.
  23. ^ Li, Yi-Rong, Shiming Li, and Chi-Chien Lin. Effect of resveratrol and pterostilbene on aging and longevity BioFactors 44, no. 1 (December 2017): 69–82. https://doi.org/10.1002/biof.1400.
  24. ^ Chang, Jaewon, Agnes Rimando, Merce Pallas, Antoni Camins, David Porquet, Jennifer Reeves, Barbara Shukitt-Hale, Mark A. Smith, James A. Joseph, and Gemma Casadesus. Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer s disease Neurobiology of Aging 33, no. 9 (September 2012): 2062–71. https://doi.org/10.1016/j.neurobiolaging.2011.08.015.
  25. ^ Riche, Daniel M., Krista D. Riche, Chad T. Blackshear, Corey L. McEwen, Justin J. Sherman, Marion R. Wofford, and Michael E. Griswold. Pterostilbene on Metabolic Parameters: A Randomized, Double-Blind, and Placebo-Controlled Trial Evidence-Based Complementary and Alternative Medicine 2014 (2014): 1–8. https://doi.org/10.1155/2014/459165.
  26. ^ Cuyàs, Elisabet, Sara Verdura, Laura Llorach-Parés, Salvador Fernández-Arroyo, Jorge Joven, Begoña Martin-Castillo, Joaquim Bosch-Barrera, et al. Metformin Is a Direct SIRT1-Activating Compound: Computational Modeling and Experimental Validation Frontiers in Endocrinology 9 (November 2018). https://doi.org/10.3389/fendo.2018.00657.
  27. ^ Picard, Frédéric, Martin Kurtev, Namjin Chung, Acharawan Topark-Ngarm, Thanaset Senawong, Rita Machado de Oliveira, Mark Leid, Michael W. McBurney, and Leonard Guarente. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR- Nature 429, no. 6993 (June 2004): 771–76. https://doi.org/10.1038/nature02583.
  28. ^ Feige, Jérôme N., Marie Lagouge, Carles Canto, Axelle Strehle, Sander M. Houten, Jill C. Milne, Philip D. Lambert, Chikage Mataki, Peter J. Elliott, and Johan Auwerx. Specific SIRT1 Activation Mimics Low Energy Levels and Protects against Diet-Induced Metabolic Disorders by Enhancing Fat Oxidation Cell Metabolism 8, no. 5 (November 2008): 347–58. https://doi.org/10.1016/j.cmet.2008.08.017.
  29. ^ Ponugoti, Bhaskar, Dong-Hyun Kim, Zhen Xiao, Zachary Smith, Ji Miao, Mengwei Zang, Shwu-Yuan Wu, Cheng-Ming Chiang, Timothy D. Veenstra, and Jongsook Kim Kemper. SIRT1 Deacetylates and Inhibits SREBP-1C Activity in Regulation of Hepatic Lipid Metabolism Journal of Biological Chemistry 285, no. 44 (September 2010): 33959–70. https://doi.org/10.1074/jbc.m110.122978.
  30. ^ Pfluger, P. T., D. Herranz, S. Velasco-Miguel, M. Serrano, and M. H. Tschop. Sirt1 protects against high-fat diet-induced metabolic damage Proceedings of the National Academy of Sciences 105, no. 28 (July 2008): 9793–98. https://doi.org/10.1073/pnas.0802917105.
  31. ^ Purushotham, Aparna, Thaddeus T. Schug, Qing Xu, Sailesh Surapureddi, Xiumei Guo, and Xiaoling Li. Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and Inflammation Cell Metabolism 9, no. 4 (April 2009): 327–38. https://doi.org/10.1016/j.cmet.2009.02.006.
  32. ^ a   b Rodgers, Joseph T., Carlos Lerin, Wilhelm Haas, Steven P. Gygi, Bruce M. Spiegelman, and Pere Puigserver. Nutrient control of glucose homeostasis through a complex of PGC-1 and SIRT1 Nature 434, no. 7029 (March 2005): 113–18. https://doi.org/10.1038/nature03354.
  33. ^ Rodgers, Joseph T., Carles Lerin, Zachary Gerhart-Hines, and Pere Puigserver. Metabolic adaptations through the PGC-1 and SIRT1 pathways FEBS Letters 582, no. 1 (November 2007): 46–53. https://doi.org/10.1016/j.febslet.2007.11.034.
  34. ^ Liu, Yi, Renaud Dentin, Danica Chen, Susan Hedrick, Kim Ravnskjaer, Simon Schenk, Jill Milne, et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange Nature 456, no. 7219 (October 2008): 269–73. https://doi.org/10.1038/nature07349.
  35. ^ Frescas, David, Luca Valenti, and Domenico Accili. Nuclear Trapping of the Forkhead Transcription Factor FoxO1 via Sirt-dependent Deacetylation Promotes Expression of Glucogenetic Genes Journal of Biological Chemistry 280, no. 21 (March 2005): 20589–95. https://doi.org/10.1074/jbc.m412357200.
  36. ^ Bordone, Laura, Maria Carla Motta, Frederic Picard, Ashley Robinson, Ulupi S Jhala, Javier Apfeld, Thomas McDonagh, et al. Sirt1 Regulates Insulin Secretion by Repressing UCP2 in Pancreatic Cells PLoS Biology Edited by Andy Dillin. 4, no. 2 (December 2005): e31. https://doi.org/10.1371/journal.pbio.0040031.
  37. ^ Grundy, Scott M. Metabolic syndrome update Trends in Cardiovascular Medicine 26, no. 4 (May 2016): 364–73. https://doi.org/10.1016/j.tcm.2015.10.004.
  38. ^ Micucci, Carla, Debora Valli, Giulia Matacchione, and Alfonso Catalano. Current perspectives between metabolic syndrome and cancer Oncotarget 7, no. 25 (March 2016). https://doi.org/10.18632/oncotarget.8341.
  39. ^ Yeung, Fan, Jamie E Hoberg, Catherine S Ramsey, Michael D Keller, David R Jones, Roy A Frye, and Marty W Mayo. Modulation of NF-B-dependent transcription and cell survival by the SIRT1 deacetylase The EMBO Journal 23, no. 12 (May 2004): 2369–80. https://doi.org/10.1038/sj.emboj.7600244.
  40. ^ Yoshizaki, Takeshi, Simon Schenk, Takeshi Imamura, Jennie L. Babendure, Noriyuki Sonoda, Eun Ju Bae, Da Young Oh, et al. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity American Journal of Physiology-Endocrinology and Metabolism 298, no. 3 (March 2010): E419–E428. https://doi.org/10.1152/ajpendo.00417.2009.
  41. ^ Hariharan, Nirmala, Yasuhiro Maejima, Jun Nakae, Jihye Paik, Ronald A. DePinho, and Junichi Sadoshima. Deacetylation of FoxO by Sirt1 Plays an Essential Role in Mediating Starvation-Induced Autophagy in Cardiac Myocytes Circulation Research 107, no. 12 (December 2010): 1470–82. https://doi.org/10.1161/circresaha.110.227371.
  42. ^ Kume, Shinji, Takashi Uzu, Kihachiro Horiike, Masami Chin-Kanasaki, Keiji Isshiki, Shin-ichi Araki, Toshiro Sugimoto, Masakazu Haneda, Atsunori Kashiwagi, and Daisuke Koya. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney Journal of Clinical Investigation 120, no. 4 (April 2010): 1043–55. https://doi.org/10.1172/jci41376.
  43. ^ Chang, Hung-Chun, and Leonard Guarente. SIRT1 Mediates Central Circadian Control in the SCN by a Mechanism that Decays with Aging Cell 153, no. 7 (June 2013): 1448–60. https://doi.org/10.1016/j.cell.2013.05.027.
  44. ^ Asher, Gad, David Gatfield, Markus Stratmann, Hans Reinke, Charna Dibner, Florian Kreppel, Raul Mostoslavsky, Frederick W. Alt, and Ueli Schibler. SIRT1 Regulates Circadian Clock Gene Expression through PER2 Deacetylation Cell 134, no. 2 (July 2008): 317–28. https://doi.org/10.1016/j.cell.2008.06.050.
  45. ^ Sahar, Saurabh, Satoru Masubuchi, Kristin Eckel-Mahan, Simone Vollmer, Luisa Galla, Nicholas Ceglia, Selma Masri, et al. Circadian Control of Fatty Acid Elongation by SIRT1 Protein-mediated Deacetylation of Acetyl-coenzyme A Synthetase 1 Journal of Biological Chemistry 289, no. 9 (January 2014): 6091–97. https://doi.org/10.1074/jbc.m113.537191.
  46. ^ Masri, Selma, Paul Rigor, Marlene Cervantes, Nicholas Ceglia, Carlos Sebastian, Cuiying Xiao, Manuel Roqueta-Rivera, et al. Partitioning Circadian Transcription by SIRT6 Leads to Segregated Control of Cellular Metabolism Cell 158, no. 3 (July 2014): 659–72. https://doi.org/10.1016/j.cell.2014.06.050.
  47. ^ Sun, Linjie, Yan Wang, Yu Song, Xiang-Rong Cheng, Shufang Xia, Md Ramim Tanver Rahman, Yonghui Shi, and Guowei Le. Resveratrol restores the circadian rhythmic disorder of lipid metabolism induced by high-fat diet in mice Biochemical and Biophysical Research Communications 458, no. 1 (February 2015): 86–91. https://doi.org/10.1016/j.bbrc.2015.01.072.
  48. ^ Zhou, Ben, Yi Zhang, Fang Zhang, Yulei Xia, Jun Liu, Rui Huang, Yuangao Wang, et al. CLOCK/BMAL1 regulates circadian change of mouse hepatic insulin sensitivity by SIRT1 Hepatology 59, no. 6 (April 2014): 2196–2206. https://doi.org/10.1002/hep.26992.
  49. ^ Wu, Aiguo, Zhe Ying, and Fernando Gomez-Pinilla. Oxidative stress modulates Sir2 in rat hippocampus and cerebral cortex European Journal of Neuroscience 23, no. 10 (May 2006): 2573–80. https://doi.org/10.1111/j.1460-9568.2006.04807.x.
  50. ^ Quintas, Ana, Alain J. de Solís, F. Javier Díez-Guerra, José M. Carrascosa, and Elena Bogónez. Age-associated decrease of SIRT1 expression in rat hippocampus Experimental Gerontology 47, no. 2 (February 2012): 198–201. https://doi.org/10.1016/j.exger.2011.11.010.
  51. ^ Michan, S., Y. Li, M. M.-H. Chou, E. Parrella, H. Ge, J. M. Long, J. S. Allard, et al. SIRT1 Is Essential for Normal Cognitive Function and Synaptic Plasticity Journal of Neuroscience 30, no. 29 (July 2010): 9695–9707. https://doi.org/10.1523/jneurosci.0027-10.2010.
  52. ^ Gao, Jun, Wen-Yuan Wang, Ying-Wei Mao, Johannes Gräff, Ji-Song Guan, Ling Pan, Gloria Mak, Dohoon Kim, Susan C. Su, and Li-Huei Tsai. A novel pathway regulates memory and plasticity via SIRT1 and miR-134 Nature 466, no. 7310 (July 2010): 1105–9. https://doi.org/10.1038/nature09271.
  53. ^ Vingtdeux, Valérie, Luca Giliberto, Haitian Zhao, Pallavi Chandakkar, Qingli Wu, James E. Simon, Elsa M. Janle, et al. AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid- Peptide Metabolism Journal of Biological Chemistry 285, no. 12 (January 2010): 9100–9113. https://doi.org/10.1074/jbc.m109.060061.
  54. ^ Karuppagounder, Saravanan S., John T. Pinto, Hui Xu, Huan-Lian Chen, M. Flint Beal, and Gary E. Gibson. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer s disease Neurochemistry International 54, no. 2 (February 2009): 111–18. https://doi.org/10.1016/j.neuint.2008.10.008.
  55. ^ Kim, Dohoon, Minh Dang Nguyen, Matthew M Dobbin, Andre Fischer, Farahnaz Sananbenesi, Joseph T Rodgers, Ivana Delalle, et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer s disease and amyotrophic lateral sclerosis The EMBO Journal 26, no. 13 (June 2007): 3169–79. https://doi.org/10.1038/sj.emboj.7601758.
  56. ^ Qin, Weiping, Tianle Yang, Lap Ho, Zhong Zhao, Jun Wang, Linghong Chen, Wei Zhao, et al. Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction Journal of Biological Chemistry 281, no. 31 (June 2006): 21745–54. https://doi.org/10.1074/jbc.m602909200.
  57. ^ Julien, Carl, Cyntia Tremblay, Vincent Émond, Meryem Lebbadi, Norman Salem, David A. Bennett, and Frédéric Calon. Sirtuin 1 Reduction Parallels the Accumulation of Tau in Alzheimer Disease Journal of Neuropathology & Experimental Neurology 68, no. 1 (January 2009): 48–58. https://doi.org/10.1097/nen.0b013e3181922348.
  58. ^ Singh, Preeti, Peter S. Hanson, and Christopher M. Morris. SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson’s disease BMC Neuroscience 18, no. 1 (June 2017). https://doi.org/10.1186/s12868-017-0364-1.
  59. ^ Moussa, Charbel, Michaeline Hebron, Xu Huang, Jaeil Ahn, Robert A. Rissman, Paul S. Aisen, and R. Scott Turner. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease Journal of Neuroinflammation 14, no. 1 (January 2017). https://doi.org/10.1186/s12974-016-0779-0.
  60. ^ Firestein, Ron, Gil Blander, Shaday Michan, Philipp Oberdoerffer, Shuji Ogino, Jennifer Campbell, Anupama Bhimavarapu, et al. The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth PLoS ONE Edited by Mikhail V. Blagosklonny. 3, no. 4 (April 2008): e2020. https://doi.org/10.1371/journal.pone.0002020.
  61. ^ LI, HAI-JUN, XIANG-MING CHE, WEI ZHAO, SHI-CAI HE, ZHENG-LIANG ZHANG, RUI CHEN, LIN FAN, and ZONG-LIANG JIA. Diet-induced obesity promotes murine gastric cancer growth through a nampt/sirt1/c-myc positive feedback loop Oncology Reports 30, no. 5 (August 2013): 2153–60. https://doi.org/10.3892/or.2013.2678.
  62. ^ Haigis, M. C., C.-X. Deng, L. W. S. Finley, H.-S. Kim, and D. Gius. SIRT3 Is a Mitochondrial Tumor Suppressor: A Scientific Tale That Connects Aberrant Cellular ROS, the Warburg Effect, and Carcinogenesis Cancer Research 72, no. 10 (May 2012): 2468–72. https://doi.org/10.1158/0008-5472.can-11-3633.

Topics related to Aging

view all
  • Brain-derived neurotrophic factor (BDNF)
    BDNF is a growth factor known for its influence on neuronal health and for its role in mediating the beneficial cognitive effects associated with exercise.
  • Time-restricted eating
    Time-restricted eating is a form of daily fasting wherein a person eats only during a limited time window, typically 8- to 12-hours.
  • Vitamin D
    Vitamin D is a hormone that plays critical roles in many physiological processes, such as blood pressure regulation, immune function, and cell growth.
  • Nicotinamide riboside
    Nicotinamide riboside is a precursor of NAD+, a coenzyme necessary for energy production and cellular repair. It is available from food and supplements.
  • Toll-like receptors
    Toll-like receptors are a family of pattern recognition receptors expressed on the surface of immune and other cells that play an important role in intestinal permeability and inflammaging.
  • Fasting
    Fasting – the voluntary abstinence from food and drink – is an ancient practice now widely appreciated for its beneficial effects on healthspan.